Enantioselective quantification of fluoxetine and norfluoxetine by HPLC in wastewater effluents

Chemosphere

Volumn 95, Issue , 2014, Pages 589-596

  Ribeiro, Ana R ^a,b,c   Maia, Alexandra S ^a,b   Moreira, Irina S ^b   Afonso, Carlos M ^c   Castro, Paula M L ^b   Tiritan, Maria E ^a,c  

^a INSTITUTO DE INVESTIGAÇÃO E FORMAÇÃO AVANÇADA EM CIÊNCIAS E TECNOLOGIAS DA SAÚDE   (Portugal)

^b UNIVERSIDADE CATÓLICA PORTUGUESA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Chirobiotic V; Enantioseparation; Fluoxetine; Macrocyclic antibiotic CSP; Norfluoxetine

Indexed keywords

BIODEGRADATION; ENANTIOMERS; ENANTIOSELECTIVITY; ETHANOL; FINITE DIFFERENCE METHOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLITES; ORGANIC POLLUTANTS; WASTE TREATMENT; WASTEWATER TREATMENT; WATER POLLUTION; WATER TREATMENT;

ANALYTICAL METHODOLOGY; CHIRAL STATIONARY PHASE; ENANTIOSEPARATIONS; FLUOXETINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTIONS; MACROCYCLIC ANTIBIOTICS; NORFLUOXETINE; SELECTIVITY AND SENSITIVITY;

EFFLUENTS;

AMMONIUM ACETATE; BUFFER; DRUG METABOLITE; FLUOXETINE; NORFLUOXETINE; VANCOMYCIN; WASTE WATER; WATER POLLUTANT;

AMMONIUM; DEGRADATION; LINEARITY; LIQUID CHROMATOGRAPHY; METABOLITE; PH; WASTEWATER; WATER TREATMENT;

AQUEOUS SOLUTION; ARTICLE; CHIRAL CHROMATOGRAPHY; CHIRALITY; CONTROLLED STUDY; DRUG DEGRADATION; DRUG STRUCTURE; EFFLUENT; ENANTIOMER; ENANTIOSELECTIVITY; FLOW RATE; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; MICROCOSM; PH; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; TEMPERATURE MEASUREMENT; VALIDATION PROCESS; WASTE WATER MANAGEMENT; ANALOGS AND DERIVATIVES; ANALYSIS; CHEMISTRY; ENVIRONMENTAL MONITORING; PROCEDURES; SEWAGE; STEREOISOMERISM; WASTE WATER; WATER POLLUTANT;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENVIRONMENTAL MONITORING; FLUOXETINE; STEREOISOMERISM; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84887618087     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2013.09.118     Document Type: Article

References (51)

1. Barclay V.K.H., Tyrefors N.L., Johansson I.M., Pettersson C.E. Trace analysis of fluoxetine and its metabolite norfluoxetine. Part I: development of a chiral liquid chromatography - tandem mass spectrometry method for wastewater samples. J. Chromatogr. A 2011, 1218:5587-5596.
2. Barclay V.K.H., Tyrefors N.L., Johansson I.M., Pettersson C.E. Trace analysis of fluoxetine and its metabolite norfluoxetine. Part II: enantioselective quantification and studies of matrix effects in raw and treated wastewater by solid phase extraction and liquid chromatography - tandem mass spectrometry. J. Chromatogr. A 2012, 1227:105-114.
3. Beesley T.E., Lee J.-T. Method development strategy and applications update for CHIROBIOTIC chiral stationary phases. J. Liq. Chromatogr. Relat. Technol. 2009, 32:1733-1767.
4. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environ. Sci. Technol. 2009, 43:597-603.
5. Bioanalytical Method Validation: Guidance for Industry, 2001. US Food and Drug Administration. pp. 1-22.
6. Borges K., Okano L., Pupo M., Bonato P. Enantioselective analysis of fluoxetine and norfluoxetine by LC in culture medium for application in biotransformation studies employing fungi. Chromatographia 2009, 70:1335-1342.
7. Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A., Banks K.E., Johnson R.D., Lewis R.J. Determination of select antidepressants in fish from an effluent-dominated stream. Environ. Toxicol. Chem. 2005, 24:464-469.
8. Brooks B.W., Turner P.K., Stanley J.K., Weston J.J., Glidewell E.A., Foran C.M., Slattery M., La Point T.W., Huggett D.B. Waterborne and sediment toxicity of fluoxetine to select organisms. Chemosphere 2003, 52:135-142.
9. Bruce G.M., Pleus R.C., Snyder S.A. Toxicological relevance of pharmaceuticals in drinking water. Environ. Sci. Technol. 2010, 44:5619-5626.
10. Bueno J.S., Silva B.J.G., Queiroz M.E.C. Enantioselective analysis of fluoxetine and norfluoxetine in plasma samples by protein precipitation and liquid chromatography with fluorescence detection. J. Braz. Chem. Soc. 2011, 22:1221-1228.
11. Cass Q.B., Degani A.L.G., Cassiano N.M. Effects on enantioselectivity by the use of polysaccharide-based columns by multimodal elution. J. Liq. Chromatogr. Relat. Technol. 2003, 26:2083-2101.
12. Chu S., Metcalfe C.D. Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography - tandem mass spectrometry. J. Chromatogr. A 2007, 1163:112-118.
13. De Andrés F., Castañeda G., Ríos Á. Use of toxicity assays for enantiomeric discrimination of pharmaceutical substances. Chirality 2009, 21:751-759.
14. Fernandes C., Tiritan M.E., Cass Q., Kairys V., Fernandes M.X., Pinto M. Enantioseparation and chiral recognition mechanism of new chiral derivatives of xanthones on macrocyclic antibiotic stationary phases. J. Chromatogr. A 2012, 1241:60-68.
15. Fernandes C., Brandão P., Santos A., Tiritan M.E., Afonso C., Cass Q., Pinto M. Resolution and determination of enantiomeric purity of new chiral derivatives of xanthones using polysaccharide-based stationary phases. J. Chromatogr. A 2012, 1269:143-153.
16. Fernández C., González-Doncel M., Pro J., Carbonell G., Tarazona J.V. Occurrence of pharmaceutically active compounds in surface waters of the henares-jarama-tajo river system (Madrid, Spain) and a potential risk characterization. Sci. Total Environ. 2010, 408:543-551.
17. Focazio M.J., Kolpin D.W., Barnes K.K., Furlong E.T., Meyer M.T., Zaugg S.D., Barber L.B., Thurman M.E. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States - II) untreated drinking water sources. Sci. Total Environ. 2008, 402:201-216.
18. Fong P.P., Molnar N. Norfluoxetine induces spawning and parturition in estuarine and freshwater bivalves. Bull. Environ. Contam. Toxicol. 2008, 81:535-538.
19. Foran C.M., Weston J., Slattery M., Brooks B.W., Huggett D.B. Reproductive assessment of japanese medaka (Oryzias latipes) following a four-week fluoxetine (SSRI) exposure. Arch. Environ. Contam. Toxicol. 2004, 46:511-517.
20. Fuller R.W., Snoddy H.D., Krushinski J.H., Robertson D.W. Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo. Neuropharmacology 1992, 31:997-1000.
21. Gonzalez-Rey M., Bebianno M.J. Does selective serotonin reuptake inhibitor (SSRI) fluoxetine affects mussel Mytilus galloprovincialis?. Environ. Pollut. 2013, 173:200-209.
22. Gros M., Petrović M., Barceló D. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal. Chem. 2008, 81:898-912.
23. Hashem H., Tründelberg C., Attef O., Jira T. Effect of chromatographic conditions on liquid chromatographic chiral separation of terbutaline and salbutamol on Chirobiotic V column. J. Chromatogr. A 2011, 1218:6727-6731.
24. Higashi Y., Gao R., Fujii Y. Determination of fluoxetine enantiomers in human serum and urine by isocratic HPLC and pre-column fluorescence derivatization with (R)-(+)-4-nitro-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole. J. Liq. Chromatogr. Relat. Technol. 2010, 33:481-490.
25. MacLeod S.L., Sudhir P., Wong C.S. Stereoisomer analysis of wastewater-derived b-blockers, selective serotonin re-uptake inhibitors, and salbutamol by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2007, 1170:23-33.
26. Madureira T.V., Barreiro J.C., Rocha M.J., Cass Q.B., Tiritan M.E. Pharmaceutical trace analysis in aqueous environmental matrices by liquid chromatography-ion trap tandem mass spectrometry. J. Chromatogr. A 2009, 1216:7033-7042.
27. Madureira T.V., Rocha M.J., Cass Q.B., Tiritan M.E. Development and optimization of a HPLC-DAD method for the determination of diverse pharmaceuticals in estuarine surface waters. J. Chromatogr. Sci. 2010, 48:176-182.
28. Olsen B.A., Wirth D.D., Larew J.S. Determination of fluoxetine hydrochloride enantiomeric excess using high-performance liquid chromatography with chiral stationary phases. J. Pharm. Biomed. Anal. 1998, 17:623-630.
29. Paterson G., Metcalfe C.D. Uptake and depuration of the anti-depressant fluoxetine by the Japanese medaka (Oryzias latipes). Chemosphere 2008, 74:125-130.
30. Pichini S., Pacifici R., Altieri I., Pellegrini M., Zuccaro P. Stereoselective determination of fluoxetine and norfluoxetine enantiomers in plasma samples by high-performance liquid chromatography. J. Liq. Chromatogr. Relat. Technol. 1996, 19:1927-1935.
31. Ramirez A.J., Brain R.A., Usenko S., Mottaleb M.A., O'Donnell J.G., Stahl L.L., Wathen J.B., Snyder B.D., Pitt J.L., Perez-Hurtado P., Dobbins L.L., Brooks B.W., Chambliss C.K. Occurrence of pharmaceuticals and personal care products in fish: results of a national pilot study in the united states. Environ. Toxicol. Chem. 2009, 28:2587-2597.
32. Ramirez A.J., Mottaleb M.A., Brooks B.W., Chambliss C.K. Analysis of pharmaceuticals in fish using liquid chromatography-tandem mass spectrometry. Anal. Chem. 2007, 79:3155-3163.
33. Ribeiro A.R., Afonso C.M., Castro P.M.L., Tiritan M.E. Enantioselective biodegradation of pharmaceuticals, alprenolol and propranolol, by an activated sludge inoculum. Ecotoxicol. Environ. Saf. 2013, 87:108-114.
34. Ribeiro A.R., Afonso C.M., Castro P.M.L., Tiritan M.E. Enantioselective HPLC analysis and biodegradation of atenolol, metoprolol and fluoxetine. Environ. Chem. Lett. 2013, 11:83-90.
35. Ribeiro A.R., Gonçalves V.M.F., Maia A.S., Carvalho M.F., Castro P.M.L., Tiritan M.E. Microbial degradation of pharmaceuticals followed by a simple HPLC-DAD method. J. Environ. Sci. Health Part A Toxic-Hazard. Subst. Environ. Eng. 2012, 47:2151-2158.
36. Sandra P., Vanhoenacker G., David F., Sandra K., Pereira A. Green chromatography (Part 1): introduction and liquid chromatography. LCGC Europe 2010, 23.
37. Santos L.H.M.L.M., Gros M., Rodriguez-Mozaz S., Delerue-Matos C., Pena A., Barceló D., Montenegro M.C.B.S.M. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: Identification of ecologically relevant pharmaceuticals. Sci. Total Environ. 2013, 461-462:302-316.
38. Schultz M.M., Furlong E.T. Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. Anal. Chem. 2008, 80:1756-1762.
39. Schultz M.M., Painter M.M., Bartell S.E., Logue A., Furlong E.T., Werner S.L., Schoenfuss H.L. Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows. Aquat. Toxicol. 2011, 104:38-47.
40. Scriba G.E. Chiral recognition mechanisms in analytical separation sciences. Chromatographia 2012, 75:815-838.
41. Silva B.J.G., Lanças F.M., Queiroz M.E.C. Determination of fluoxetine and norfluoxetine enantiomers in human plasma by polypyrrole-coated capillary in-tube solid-phase microextraction coupled with liquid chromatography-fluorescence detection. J. Chromatogr. A 2009, 1216:8590-8597.
42. Sousa E.P., Tiritan M.E., Oliveira R.V., Afonso C.M.M., Cass Q.B., Pinto M.M.M. Enantiomeric resolution of kielcorin derivatives by HPLC on polysaccharide stationary phases using multimodal elution. Chirality 2004, 16:279-285.
43. Stanley J.K., Brooks B.W. Perspectives on ecological risk assessment of chiral compounds. Integr. Environ. Assess. Manage. 2009, 5:364-373.
44. Stanley J.K., Ramirez A.J., Chambliss C.K., Brooks B.W. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 2007, 69:9-16.
45. Stokes P.E., Holtz A. Fluoxetine tenth anniversary update: the progress continues. Clin. Ther. 1997, 19:1135-1250.
46. Trenholm R.A., Vanderford B.J., Holady J.C., Rexing D.J., Snyder S.A. Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry. Chemosphere 2006, 65:1990-1998.
47. Unceta N., Barrondo S., de Azúa I.R., Gómez-Caballero A., Goicolea M.A., Sallés J., Barrio R.J. Determination of fluoxetine, norfluoxetine and their enantiomers in rat plasma and brain samples by liquid chromatography with fluorescence detection. J. Chromatogr. B 2007, 852:519-528.
48. Validation of Analytical Procedures: Text and Methodology Q2(R1), 1996. In: International Conference on Harmonization, pp. 1-13.
49. Vasskog T., Anderssen T., Pedersen-Bjergaard S., Kallenborn R., Jensen E. Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway. J. Chromatogr. A 2008, 1185:194-205.
50. Yee L., Wong S.H.Y., Skrinska V.A. Chiral high-performance liquid chromatographic analysis of fluoxetine and norfluoxetine in rabbit plasma, urine, and vitreous humor using an acetylated β-cyclodextrin column. J. Anal. Toxicol. 2000, 24:651-655.
51. Zhou J., Ren Q., Wu P. Chromatographic separation of fluoxetine hydrochloride enantiomers by cellulose chiral stationary phase. J. Liq. Chromatogr. Relat. Technol. 2005, 28:3229-3242.